REMICADE®

REMICADE® (Infliximab) is an immunosuppressive drug that is used in the treatment of Inflammatory Bowel Disease, as well as other autoimmune diseases.

REMICADE® is manufactured by Janssen Biotech.

Administration and Dosage:

Administration of REMICADE® follows an induction regimen of 3 intravenous infusions at week 0, 2, and 6 followed by a maintenance infusion then every 8 weeks for maintenance.

Common Side Effects:

The more common side effects of REMICADE® include respiratory infections (such as sinus infections and sore throat), headache, coughing and stomach pain.

More information:

Please read the full Prescribing Information and Medication Guide for REMICADE® and discuss any questions you have with your doctor.

Indication:

REMICADE® is indicated to treat:

  • Crohn’s Disease

  • Ulcerative Colitis

  • Pediatric Ulcerative Colitis

  • Pediatric Crohn’s Disease

  • Rheumatoid Arthritis

  • Ankylosing Spondylitis

  • Psoriatic Arthritis

  • Plaque Psoriasis

Contact Us

Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!

Check our Privacy Practice